Meanwhile, the tumor weight was tested after silencing FOXD2-AS1 in vivo, and the results indicated that tumor weight was apparently inhibited by decreasing FOXD2-AS1 (Figure 4E), and the same trend was found in the cell lines U87TR and U251TR. The gene discussed is FOXD2; the disease is neoplasm.